etidronate has been researched along with DDD MPGNII in 1 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Excerpt | Relevance | Reference |
---|---|---|
"A 56-yr-old male developed a systemic illness while receiving cyclical oral etidronate therapy for idiopathic osteoporosis." | 4.78 | Idiopathic polymyositis complicated by arthritis and mesangial proliferative glomerulonephritis: case report and review of the literature. ( Bhalla, AK; Frost, NA; Hall, CL; Maddison, PJ; Morand, EF, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frost, NA | 1 |
Morand, EF | 1 |
Hall, CL | 1 |
Maddison, PJ | 1 |
Bhalla, AK | 1 |
1 review available for etidronate and DDD MPGNII
Article | Year |
---|---|
Idiopathic polymyositis complicated by arthritis and mesangial proliferative glomerulonephritis: case report and review of the literature.
Topics: Arthritis; Etidronic Acid; Glomerulonephritis, Membranoproliferative; Humans; Male; Middle Aged; Ost | 1993 |